Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Breast Milk for Neonatal HIE (NEO-BRIGHT)
NCT06746532Phase 1Recruiting
- Sponsor
- Semmelweis University
- Start
- Feb 2025
- Primary completion
- Jan 2028
- Modality
- Nutraceutical
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of human milk in hypoxic-ischemic encephalopathy (HIE) (2 arms), sponsored by Semmelweis University. Primary endpoint: Neurodevelopmental outcome at 2 years. Started Feb 2025; status: recruiting.
02
Drugs
human milk
03
Conditions
hypoxic-ischemic encephalopathy (HIE)
Beyond the preview
Go deeper on NCT06746532.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06746532.